Search Results

DES Shows Superiority to BMS in Treatment of CLI

December 15, 2011—Marc Bosiers, MD, et al concluded that treatment of infrapopliteal occlusive lesions in critical limb ischemia (CLI) with everolimus-eluting stents results in a greater reduction of restenosis and the need for reintervention compared with bare-metal stents in the DESTINY study published online ahead of print in the Journal of Vascular Surgery.

European Studies Evaluate Carotid Artery Stenting Devices

August 23, 2016—Two studies of carotid artery stenting were published online in EuroIntervention. Marc Bosiers, MD, et al reported findings from the CLEAR-ROAD study (2016;12:e671–e676). Eugenio Stabile, MD, et al evaluated the impact on the outcome of different types of carotid stents in the European Registry of Carotid Artery Stenting (2016;12:e265–e270).

Covidien Begins DURABILITY and VISIBILITY Iliac Studies

August 4, 2011—Covidien (Mansfield, MA) announced the commencement of enrollment in the DURABILITY Iliac and VISIBILITY Iliac studies.

One-Year ASTI Data Support Boston Scientific's Adapt Carotid Stent With FilterWire EZ Distal Protection in High-Surgical-Risk Patients

April 8, 2015—Marc Bosiers, MD, et al published results of the European ASTI trial in CardioVascular and Interventional Radiology (2015;38:295–303). ASTI is a prospective, multicenter, nonrandomized study evaluating the periprocedural and 1-year outcomes in high-surgical-risk patients with carotid artery stenosis treated with the Adapt carotid stent plus FilterWire EZ distal protection catheter (Boston Scientific Corporation).

Stentys Self-Apposing Stent Evaluated for CLI Treatment

January 28, 2015—Stentys announced that its Self-Apposing drug-eluting stent was evaluated in 70 patients with critical limb ischemia (CLI) and prevented foot amputation in 99% of these patients.

Intact Vascular's Tack Endovascular System Supported by 12-Month TOBA Data

January 27, 2015—Intact Vascular, Inc. announced that 12-month results from the TOBA (Tack Optimized Balloon Angioplasty) clinical trial were presented by Coprincipal Investigator Marc Bosiers, MD, at LINC 2015: the Leipzig Interventional Course in Leipzig, Germany.

Two-Year ZILVERPASS Data Compares Cook Medical's Zilver PTX Versus Surgery

November 20, 2019—Cook Medical announced data supporting the use of the company’s Zilver PTX paclitaxel-coated stent for the treatment of peripheral artery disease (PAD) were presented by Marc Bosiers, MD, at the VEITHsymposium held November 19–23 in New York, New York.

Abbott Initiates International ABSORB BTK Trial

September 8, 2011—Abbott Vascular (Santa Clara, CA) announced the initiation of ABSORB BTK, an international clinical trial evaluating the company's everolimus-eluting Absorb bioresorbable vascular scaffold (BVS) for the treatment of below-the-knee (BTK) critical limb ischemia.